### Cardinal Health Accelerates Specialty and At-Home Growth with Double Acquisition

**DUBLIN, Ohio, Nov. 11, 2024** – Cardinal Health (NYSE: CAH) has announced definitive agreements to acquire two significant companies, aiming to enhance its strategic growth areas and improve patient care. These acquisitions align with the company's capital deployment strategy and long-term vision.

Cardinal Health has agreed to acquire a majority stake in GI Alliance (GIA), the nation's leading gastroenterology management services organization, for approximately $2.8 billion in cash. This transaction will grant Cardinal Health 71% ownership of GIA, which will be integrated into the company’s Pharmaceutical and Specialty Solutions segment.

In a separate agreement, Cardinal Health will acquire Advanced Diabetes Supply Group (ADSG), a premier national provider of diabetes medical supplies, for around $1.1 billion in cash. ADSG is expected to merge with Cardinal Health's at-Home Solutions business, reinforcing its position in the market.

Jason Hollar, CEO of Cardinal Health, emphasized that these acquisitions are pivotal for the company's growth in specialty services and at-home care solutions. He noted that the company's systematic focus on growth over the past two years has significantly improved its operational and financial flexibility.

GI Alliance operates across 345 practice locations in 20 states, supporting over 900 physicians. This large network includes 135 ambulatory surgical centers, 165 hospital networks, and 95 infusion centers, making it a comprehensive platform for gastroenterology services.

Advanced Diabetes Supply Group serves about 500,000 patients annually, offering the latest in diabetes treatment innovations. This acquisition is expected to enhance Cardinal Health's ability to support the growing at-home patient population with tailored diabetes management solutions.

Cardinal Health plans to finance these acquisitions with a mix of available cash and new debt financing. The company will focus on paying down debt over the next 18 to 24 months without altering its share repurchase plans for fiscal year 2025.

Both transactions are anticipated to close in early 2025, subject to regulatory approvals. Cardinal Health expects these acquisitions to be accretive to revenue and profit growth within the first 12 months following their closure. The company will provide further financial guidance after the transactions are finalized.

Cardinal Health will discuss these strategic acquisitions in a webcast set for Tuesday at 8:45 AM ET. Details and a replay of the presentation will be available on the company's Investor Relations webpage. The company also plans to host an Investor Day in New York City on June 12, 2025, which will be live-webcast and archived online for future reference.